BACKGROUND AND PURPOSE: The precise mechanism/s of action of ethanol, although studied for many years, are not well understood. Like other drugs of abuse, ethanol affects dopamine levels in the nucleus accumbens (nAc), an important region of the mesolimbic system, causing a reinforcing effect. It has been shown that glycine receptors (GlyRs) present in the nAc are potentiated by clinically relevant concentrations of ethanol, where α1 and α2 are the predominant subunits expressed. EXPERIMENTAL APPROACH: Using a combination of electrophysiology and behavioural assays, we studied the involvement of GlyR α2 subunits on the effects of low and high doses of ethanol, as well as on consumption using mice lacking the GlyR α2 subunit (male Glra2-/Y and female Glra2-/- ). KEY RESULTS: GlyR α2 subunits exist in accumbal neurons, since the glycine-evoked currents and glycinergic miniature inhibitory postsynaptic currents (mIPSCs) in Glra2-/Y mice were drastically decreased. In behavioural studies, differences in ethanol consumption and sedation were observed between wild-type (WT) and Glra2 knockout (KO) mice. Using the drinking in the dark (DID) paradigm, we found that Glra2-/Y mice presented a binge-like drinking behaviour immediately when exposed to ethanol rather than the gradual consumption seen in WT animals. Interestingly, the effect of knocking out Glra2 in female (Glra2-/- ) mice was less evident, since WT female mice already showed higher DID. CONCLUSION AND IMPLICATIONS: The differences in ethanol consumption between WT and KO mice provide additional evidence supporting the conclusion that GlyRs are biologically relevant targets for the sedative and rewarding properties of ethanol.
BACKGROUND AND PURPOSE: The precise mechanism/s of action of ethanol, although studied for many years, are not well understood. Like other drugs of abuse, ethanol affects dopamine levels in the nucleus accumbens (nAc), an important region of the mesolimbic system, causing a reinforcing effect. It has been shown that glycine receptors (GlyRs) present in the nAc are potentiated by clinically relevant concentrations of ethanol, where α1 and α2 are the predominant subunits expressed. EXPERIMENTAL APPROACH: Using a combination of electrophysiology and behavioural assays, we studied the involvement of GlyR α2 subunits on the effects of low and high doses of ethanol, as well as on consumption using mice lacking the GlyR α2 subunit (male Glra2-/Y and female Glra2-/- ). KEY RESULTS: GlyR α2 subunits exist in accumbal neurons, since the glycine-evoked currents and glycinergic miniature inhibitory postsynaptic currents (mIPSCs) in Glra2-/Y mice were drastically decreased. In behavioural studies, differences in ethanol consumption and sedation were observed between wild-type (WT) and Glra2 knockout (KO) mice. Using the drinking in the dark (DID) paradigm, we found that Glra2-/Y mice presented a binge-like drinking behaviour immediately when exposed to ethanol rather than the gradual consumption seen in WT animals. Interestingly, the effect of knocking out Glra2 in female (Glra2-/- ) mice was less evident, since WT female mice already showed higher DID. CONCLUSION AND IMPLICATIONS: The differences in ethanol consumption between WT and KO mice provide additional evidence supporting the conclusion that GlyRs are biologically relevant targets for the sedative and rewarding properties of ethanol.
Authors: A Avila; P M Vidal; S Tielens; G Morelli; S Laguesse; R J Harvey; J-M Rigo; L Nguyen Journal: Cell Death Differ Date: 2014-06-13 Impact factor: 15.828
Authors: Lindsay M McCracken; Daniel C Lowes; Michael C Salling; Cyndel Carreau-Vollmer; Naomi N Odean; Yuri A Blednov; Heinrich Betz; R Adron Harris; Neil L Harrison Journal: Proc Natl Acad Sci U S A Date: 2017-08-07 Impact factor: 11.205
Authors: J H Ye; L Tao; J Ren; R Schaefer; K Krnjevic; P L Liu; D A Schiller; J J McArdle Journal: J Pharmacol Exp Ther Date: 2001-01 Impact factor: 4.030
Authors: M D Scofield; J A Heinsbroek; C D Gipson; Y M Kupchik; S Spencer; A C W Smith; D Roberts-Wolfe; P W Kalivas Journal: Pharmacol Rev Date: 2016-07 Impact factor: 25.468
Authors: Yuri A Blednov; S Jung; H Alva; D Wallace; T Rosahl; P-J Whiting; R Adron Harris Journal: J Pharmacol Exp Ther Date: 2003-01 Impact factor: 4.030
Authors: Xiumin Chen; Katie A Wilson; Natascha Schaefer; Lachlan De Hayr; Mark Windsor; Emmanuel Scalais; Germaine van Rijckevorsel; Katrien Stouffs; Carmen Villmann; Megan L O'Mara; Joseph W Lynch; Robert J Harvey Journal: Front Mol Neurosci Date: 2022-04-29 Impact factor: 6.261
Authors: Loreto S San Martin; Lorena Armijo-Weingart; Anibal Araya; Gonzalo E Yévenes; Robert J Harvey; Luis G Aguayo Journal: Front Mol Neurosci Date: 2021-10-22 Impact factor: 5.639